[Epidemiology and diagnosis strategy: CNGOF-HAS Endometriosis Guidelines]
Guideline
OA: closed
CC0
⤵ 13 in-corpus citations
AI-generated summary
This paper presents the epidemiology and diagnostic strategy for endometriosis according to the CNGOF-HAS clinical practice guidelines.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Based on the best evidence available, we have provided guidelines for clinical practice to target the nature of endometriosis as a disease, the consequences of its natural history on management, and the clinical and imaging evaluation of the disease according to the level of care (primary care, specialized or referral). The frequency of endometriosis is unknown in the general population; endometriosis requires management when it causes symptoms (pain, infertility) or when it affect the function of an organ. In the absence of symptom, there is no need for follow-up or screening of the disease. Endometriosis may be responsible for various pain symptoms such as severe dysmenorrhea, deep dyspareunia, painful bowel movements or low urinary tract signs increasing with menstruation, or infertility. A careful evaluation of the symptoms and their impact on the quality of life should be made. The first-line examinations for the diagnosis of endometriosis are: digital examination and pelvic ultrasound. The second-line examinations are: the pelvic exam by an expert clinician, the pelvic MRI and/or the transvaginal ultrasound by an expert. MRI and ultrasound carrying different and complementary information. Other examinations may be considered as part of the pre-therapeutic assessment of the disease in case of specialized care. Diagnostic laparoscopy may be suggested in case of clinical suspicion of endometriosis whereas preoperative examinations have not proved the disease, it must be part of a management plan of endometriosis-related pain or infertility. During management, it is recommended to give comprehensive information on the different therapeutic alternatives, the benefits and risks expected from each treatment, the risk of recurrence, fertility, especially before surgery. The information must be personalized and take into account the expectations and preferences of the patient, and accompanied by an information notice given to the patient.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (13)
- A systematic approach to standardizing the visual appearance of endometriotic lesions for artificial intelligence recognition 2026
- Endométriose et qualité de vie : le rôle du soutien social et des stratégies de coping 2023
- Medical management of psoas muscle deep endometriosis: A case report 2021
- Prendre en charge une patiente atteinte d’endométriose 2021
- [How I do… Resection of the uterosacral ligament by laparoscopy with nerve sparing in 6 steps] 2020
- Menstruation: science and society 2020
- Spontaneous pregnancy rate following surgery for deep infiltrating endometriosis in infertile women: The impact of the learning curve 2020
- Expression of nerve growth factor (NGF) in endometrium as a potential biomarker for endometriosis - Single tertiary care centre study 2020
- Immune system cells as biomarkers in the diagnostics of endometriosis 2019
- Management of endometriosis: CNGOF/HAS clinical practice guidelines - Short version 2018
- Comparison of 3-Tesla to 1.5-Tesla Magnetic Resonance Enterography to assess multifocal and multicentric bowel endometriosis: Results in routine practice 2018
- [Management of endometriosis: CNGOF-HAS practice guidelines (short version)] 2018
- [Contribution of meb to endometriosis patients' diagnosis and treatment] 2018
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:21:42.149903+00:00
License: CC0
· commercial use OK